title: Total intravenous anesthesia versus single breath technique and anesthesia maintenance with sevoflurane for bariatric operations.
abstract: BACKGROUND
  The choice of anesthetic technique for general anesthesia in morbidly obese patients remains controversial. We aimed to compare blood gases, recovery and hemodynamic parameters using TIVA and sevoflurane anesthesia in bariatric surgery.
  
  
  METHODS
  The study was performed with permission of the ethics committee. We studied 40 morbidly obese patients allocated to 2 groups. The total i.v. anesthesia (TIVA) group was named Group T, and the sevoflurane group was named Group S. In Group T, anesthesia induction was achieved with propofol. In Group S, anesthesia induction was achieved by sevoflurane with single breath technique, with maintenance provided with 1-2% volume sevoflurane. Student t, Chi square and ANOVA tests were used for data analysis; p-value < 0.05 was considered statistically significant.
  
  
  RESULTS
  There was no significant difference between the 2 groups in demographic data, blood gas values and recovery characteristic. Hemodynamic values were significantly lower in Group T than Group S, during and after the operative period.
  
  
  CONCLUSIONS
  While sevoflurane induction and maintenance is a suitable anesthetic modality for obese patients, TIVA can be applied easily in those patients possessing no extra risk factors other than morbid obesity.
authors.affiliation: University of Istanbul, Medical Faculty of Cerrahpasa, Department of Anesthesiology, Istanbul, Turkey. zsalihoglu@yahoo.com
authors.forename: Z
authors.initials: Z
authors.lastname: Salihoglu
authors.forename: S
authors.initials: S
authors.lastname: Karaca
authors.forename: Y
authors.initials: Y
authors.lastname: Kose
authors.forename: K
authors.initials: K
authors.lastname: Zengin
authors.forename: M
authors.initials: M
authors.lastname: Taskin
mesh_terms: D000328:Adult; D015760:Alfentanil / Q000627:therapeutic use*; D000704:Analysis of Variance; D000762:Anesthesia Recovery Period; D000769:Anesthesia, Inhalation / Q000009:adverse effects / Q000379:methods*; D000771:Anesthesia, Intravenous / Q000009:adverse effects / Q000379:methods*; D018685:Anesthetics, Inhalation / Q000627:therapeutic use*; D018686:Anesthetics, Intravenous / Q000627:therapeutic use*; D001784:Blood Gas Analysis; D016009:Chi-Square Distribution; D004359:Drug Therapy, Combination; D005260:Female; D015391:Gastroplasty; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008738:Methyl Ethers / Q000627:therapeutic use*; D008875:Middle Aged; D009767:Obesity, Morbid / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery*; D015742:Propofol / Q000627:therapeutic use*; D012307:Risk Factors; D000077149:Sevoflurane; D016896:Treatment Outcome
chemical_list: D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D008738:Methyl Ethers; D015760:Alfentanil; D000077149:Sevoflurane; D015742:Propofol